Transcripts
ProMIS Neurosciences (PMN) earnings call transcripts
Earnings call transcripts for ProMIS Neurosciences Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed the blinded interim results as initial human support for PMN 310’s oligomer-selective thesis, while stressing that efficacy remains unproven.
Aug 13, 2026Confident0.72